Recursion Pharmaceuticals Needs A Clinical Breakthrough To Pique Interest
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Contract Pharma1d
Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials
New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...
TMCnet2d
Cognito Therapeutics Strengthens Executive Team to Drive Next Phase of Growth and Commercialization
View the full release here: "As Cognito nears completion of enrollment in our pivotal HOPE trial and prepares for regulatory ...
Newstalk2d
Kerry medical research company starts clinical trial of ASD medication
A medical research company in County Kerry has stared clinical trials of a new drug to find a treatment for Autism Spectrum ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
ascopubs.org4d
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
Immune checkpoint blockers (ICBs) have revolutionized the treatment of non–small cell lung cancer (NSCLC). Currently, one-dose-fits-all maximalist regimens have been considered the standard of care, ...
Why Sarepta Therapeutics, Inc. (SRPT) Is Among the Best Healthcare Stocks To Buy According to Analysts
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands ...
12 Best Healthcare Stocks to Buy According to Analysts
In this article, we will discuss the 12 Best Healthcare Stocks to Buy According to Analysts. McKinsey reported that, since ...
Nasdaq15d
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX ... placebo-controlled Phase 2 clinical trial in patients with early-stage multiple system ...
Business Insider15d
Promising Clinical Developments and Strategic Collaborations Justify Buy Rating for Nurix Therapeutics
Nurix Therapeutics (NRIX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeet Mukherjee from BTIG assigned a Buy rating on the stock ...